After adjusting for BMI, fasting glucose levels, diabetes, smoking, and CRP levels, independent of other cardiovascular risk factors, every 1 pmol/L increase in sclerostin levels was associated with a 5.4% increase in the risk of developing PAD. The gene discussed is CRP; the disease is peripheral arterial disease.